Evidence map›Paper›PMID 41092581›Full record

ArticleEBioMedicine2025

Consistent performance of large language models in rare disease diagnosis across ten languages and 4917 cases.

Leonardo Chimirri, J Harry Caufield, Yasemin Bridges, Nicolas Matentzoglu, Michael Gargano, Mario Cazalla, Shihan Chen, Daniel Danis, Alexander J M Dingemans, Klara Gehle and 20 more

Abstract read
In one paragraph

Article in EBioMedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Disparate language and model effects on AI-based translation and recognition of genetic conditions.Journal of the American Medical Informatics Association : JAMIA · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. GEN-KnowRD: Reframing AI for Rare Disease Recognition.medRxiv : the preprint server for health sciences · 2026
    Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

30 authors.

Leonardo ChimirriBerlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
J Harry CaufieldLawrence Berkeley National Laboratory, Berkeley, CA, USA.
Yasemin BridgesWilliam Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Nicolas MatentzogluSemanticly, Athens, Greece.
Michael GarganoThe Jackson Laboratory for Genomic Medicine, Farmington CT, USA.
Mario CazallaINGEMM-Idipaz, Institute of Medical and Molecular Genetics, Hospital Universitario La Paz, Madrid, Spain.
Shihan ChenDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Daniel DanisBerlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
Alexander J M DingemansDepartment of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands.
Klara GehleMedical University of Gdansk, ul. M. Skłodowskiej-Curie 3a, 80-210, Gdańsk, Poland.
Petra GehleDeutsches Herzzentrum der Charité, Berlin, Germany.
Adam S L GraefeBerlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
Weihong GuChinese HPO Consortium, Beijing, China.
Markus S LadewigDepartment of Ophthalmology, University Clinic Marburg - Campus Fulda, Fulda, Germany.
Pablo LapunzinaINGEMM-Idipaz, Institute of Medical and Molecular Genetics, Hospital Universitario La Paz, Madrid, Spain; CIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, Instituto de Salud Carlos (ISCIII), Madrid, Spain.
Julián NevadoINGEMM-Idipaz, Institute of Medical and Molecular Genetics, Hospital Universitario La Paz, Madrid, Spain; CIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, Instituto de Salud Carlos (ISCIII), Madrid, Spain.
Enock NiyonkuruLawrence Berkeley National Laboratory, Berkeley, CA, USA; Trinity College, Hartford, CT, USA.
Soichi OgishimaINGEM/ToMMo, Tohoku University, Miyagi, Japan.
Dominik SeelowBerlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
Jair A Tenorio CastañoINGEMM-Idipaz, Institute of Medical and Molecular Genetics, Hospital Universitario La Paz, Madrid, Spain.
Marek TurnovecDepartment of Biology and Medical Genetics, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic.
Bert B A de VriesDepartment of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands.
Kai WangDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Kyran WissinkBerlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany; Utrecht University, Utrecht, Netherlands.
Zafer YükselDepartment of Human Genetics, Bioscientia Healthcare GmbH, Ingelheim, Germany.
Gabriele ZuccaInstitute for Maternal and Child Health - IRCCS "Burlo Garofolo" - Trieste, Trieste, 34137, Italy.
Melissa A HaendelUniversity of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Christopher J MungallLawrence Berkeley National Laboratory, Berkeley, CA, USA.
Justin ReeseLawrence Berkeley National Laboratory, Berkeley, CA, USA. Electronic address: justinreese@lbl.gov.
Peter N RobinsonBerlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany; The Jackson Laboratory for Genomic Medicine, Farmington CT, USA. Electronic address: peter.robinson@bih-charite.de.

Funding

The Monarch Initiative: Linking Diseases to Model Organism ResourcesR24OD011883 · OD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HAENDEL, MELISSA A, MUNGALL, CHRISTOPHER J · 2012 to 2024
$16.0M
Improvements to the LinkML framework to support the Phenomics First open science resourceRM1HG010860 · NHGRI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HAENDEL, MELISSA A, MUNGALL, CHRISTOPHER J · 2020 to 2024
$10.3M
The Human Phenotype Ontology: Accelerating Computational Integration of Clinical Data for GenomicsU24HG011449 · NHGRI · JACKSON LABORATORY · PI Peter Nicholas Robinson · 2021 to 2026
$6.7M
Increasing the Yield and Utility of Pediatric Genomic Medicine with ExomiserR01HD103805 · NICHD · JACKSON LABORATORY · PI Valentina Cipriani, CHRISTOPHER J MUNGALL · 2021 to 2026
$4.3M
NHGRI NIH HHS RM1 HG010860NHGRI NIH HHS U24 HG011449NICHD NIH HHS R01 HD103805NIH HHS R24 OD011883
6 · The paper itself

Abstract

backgroundLarge language models (LLMs) are increasingly used medicine for diverse applications including differential diagnostic support. The training data used to create LLMs such as the Generative Pretrained Transformer (GPT) predominantly consist of English-language texts, but LLMs could be used across the globe to support diagnostics if language barriers could be overcome. Initial pilot studies on the utility of LLMs for differential diagnosis in languages other than English have shown promise, but a large-scale assessment on the relative performance of these models in a variety of European and non-European languages on a comprehensive corpus of challenging rare-disease cases is lacking.

methodsWe created 4917 clinical vignettes using structured data captured with Human Phenotype Ontology (HPO) terms with the Global Alliance for Genomics and Health (GA4GH) Phenopacket Schema. These clinical vignettes span a total of 360 distinct genetic diseases with 2525 associated phenotypic features. We used translations of the Human Phenotype Ontology together with language-specific templates to generate prompts in English, Chinese, Czech, Dutch, French, German, Italian, Japanese, Spanish, and Turkish. We applied GPT-4o, version gpt-4o-2024-08-06, and the medically fine-tuned Meditron3-70B to the task of delivering a ranked differential diagnosis using a zero-shot prompt. An ontology-based approach with the Mondo disease ontology was used to map synonyms and to map disease subtypes to clinical diagnoses in order to automate evaluation of LLM responses.

findingsFor English, GPT-4o placed the correct diagnosis at the first rank 19.9% and within the top-3 ranks 27.0% of the time. In comparison, for the nine non-English languages tested here the correct diagnosis was placed at rank 1 between 16.9% and 20.6%, within top-3 between 25.4% and 28.6% of cases. The Meditron3 model placed the correct diagnosis within the first 3 ranks for 20.9% of cases in English and between 19.9% and 24.0% for the other nine languages.

interpretationThe differential diagnostic performance of LLMs across a comprehensive corpus of rare-disease cases was largely consistent across the ten languages tested. This suggests that the utility of LLMs in clinical settings may extend to non-English clinical settings.

fundingNHGRI 5U24HG011449, 5RM1HG010860, R01HD103805 and R24OD011883. P.N.R. was supported by a Professorship of the Alexander von Humboldt Foundation; P.L. was supported by a National Grant (PMP21/00063 ONTOPREC-ISCIII, Fondos FEDER). C.M., J.R. and J.H.C. were supported in part by the Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy (Contract No. DE-AC0205CH11231).

Indexed as

LanguageRare DiseasesDiagnosis, DifferentialHumansLarge Language ModelsPhenotypeArtificial intelligenceGenomic diagnosticsGlobal Alliance for Genomics and HealthHuman phenotype ontologyLarge language modelPhenopacket schema

Identifiers

PMID41092581
PMCPMC12552141

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.